HBB rs334, ABO Rs8176703and Plasmodium FalciparumPositivity at Enrollment Are Independently Associated with Lower Risk for Endemic Burkitt Lymphoma in Uganda, Tanzania, Kenya, and Malawi

MLA

Hong, Hyokyoung G., et al. “HBB Rs334, ABO Rs8176703and Plasmodium FalciparumPositivity at Enrollment Are Independently Associated with Lower Risk for Endemic Burkitt Lymphoma in Uganda, Tanzania, Kenya, and Malawi.” Blood, vol. 140, no. 1, Number 1 Supplement 1, Nov. 2022, pp. 9314–16. EBSCOhost, https://doi.org/10.1182/blood-2022-170410.

APA

Hong, H. G., Gouveia, M. H., Ogwang, M., Kerchan, P., Reynolds, S., Tenge, C. N., Were, P. A., Kuremu, R. T., Wekesa, W. N., Masalu, N., Kawira, E., Kinyera, T., Wang, X., Zhou, J., Otim, I., Legason, I. D., Nabalende, H., Dhudha, H., Mumia, M., … Mbulaiteye, S. M. (2022). HBB rs334, ABO Rs8176703and Plasmodium FalciparumPositivity at Enrollment Are Independently Associated with Lower Risk for Endemic Burkitt Lymphoma in Uganda, Tanzania, Kenya, and Malawi. Blood, 140(1, Number 1 Supplement 1), 9314–9316. https://doi.org/10.1182/blood-2022-170410

Chicago

Hong, Hyokyoung G, Mateus H Gouveia, Martin Ogwang, Patrick Kerchan, Steven Reynolds, Constance N Tenge, Pamela A Were, et al. 2022. “HBB Rs334, ABO Rs8176703and Plasmodium FalciparumPositivity at Enrollment Are Independently Associated with Lower Risk for Endemic Burkitt Lymphoma in Uganda, Tanzania, Kenya, and Malawi.” Blood 140 (1, Number 1 Supplement 1): 9314–16. doi:10.1182/blood-2022-170410.